Description
Fludarabine is highly effective in the treatment of chronic lymphocytic leukemia, producing higher response rates than alkylating agents such as chlorambucil alone.Fludarabine is used in various combinations with cyclophosphamide, mitoxantrone, dexamethasone and rituximab in the treatment of indolent non-Hodgkins lymphomas. As part of the FLAG regimen, fludarabine is used together with cytarabine and granulocyte colony-stimulating factor in the treatment of acute myeloid leukaemia. Because of its immunosuppressive effects, fludarabine is also used in some conditioning regimens prior to non myeloablative allogeneic stem cell transplant.
Synonyms
Fludarabine; 2-Fluoro Adenosine; 6-Amino-2-fluoro-9-beta-D-ribofuranosylpurine
IUPAC Name
(2R,3R,4S,5R)-2-(6-amino-2-fluoropurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol
Molecular Formula
C10H12FN5O4
Canonical SMILES
C1=NC2=C(N1C3C(C(C(O3)CO)O)O)N=C(N=C2N)F
InChI
InChI=1S/C10H12FN5O4/c11-10-14-7(12)4-8(15-10)16(2-13-4)9-6(19)5(18)3(1-17)20-9/h2-3,5-6,9,17-19H,1H2,(H2,12,14,15)/t3-,5-,6-,9-/m1/s1
InChIKey
HBUBKKRHXORPQB-UUOKFMHZSA-N
Boiling Point
747.3°C at 760 mmHg
Solubility
>42.8 [ug/mL] (The mean of the results at pH 7.4)
Appearance
White to Off-white Powder
Storage
Store at 2-8°C (under dark)